Forecasts data is unavailable for this security.
Select bar for recommendation details.
Share price forecast in USD
The 11 analysts offering 12 month price targets for
Hikma Pharmaceuticals Plc have a median target of 1,926.17, with a high estimate of 2,716.11 and a low estimate of 1,678.95. The median estimate represents a 13.34% increase from the last price of 1,699.50.
Dividends in USD
|Div growth (TTM)||-32.79%|
Earnings history & estimates in USD
|Average growth rate||+7.40%|
Revenue history & estimates in USD
|Average growth rate||+5.08%|